Alan David Armstrong

Almac Clinical Technologies, Inc. provides integrated drug development services. The company was founded in 1995 and is headquartered in Yardley, PA.

Almac Group Ltd. manufactures and distributes pharmaceutical products. The firm’s services include diagnostics, API services and chemical development, pharmaceutical development, analytical and solid state services, clinical services, clinical technologies and commercial services. The company was founded by Allen McClay in 2002 and is headquartered in Craigavon, the United Kingdom.

The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists.

Almac Group (UK) Ltd. offers contract development and manufacturing services. Its services encompass research and development, biomarker discovery and development, formulation development, clinical trial supply, IXRS technology, commercial-scale manufacture, and companion diagnostic development. The firm serves the pharmaceutical and biotechnology sectors. The company is headquartered in Craigavon, the United Kingdom.

Part of The McClay Foundation, Almac Pharma Services Ltd. is a British company that provides a range of contract pharmaceutical development and manufacturing services. The private company is based in Craigavon, UK. The company's services include adjudication of in-transit and clinical site excursions, compliance management of shipments & sites, and comprehensive GDP monitoring. The company also offers customised CDX solutions that are unique to companies worldwide. Almac Clinical Services has not experienced any significant operational impact due to the coronavirus outbreak and their service levels remain unchanged. John McQuaid has been the CEO of the company since 1994.

Part of The McClay Foundation, Almac Diagnostic Services Ltd. offers a complete range of peptide and protein services, from catalogue products to GMP manufacture, for early phase to commercial launch. The private company is based in Craigavon, UK. Almac Group provides a range of contract pharmaceutical development and manufacturing services. Almac Interactive Response Technology (IRT) technologies suite offers 3 modes to configure your IXRS platform varying in levels of customizations, speed to go live, and costs for your clinical supply chain study. The British company is one of the leading, multi-faceted, solution providers within the niche and complex market of clinical trial supply. Almac Diagnostic Services was initially founded as a spin-out company from Queen's University in 2002 called Arradx, which was incorporated into the Almac Group in 2004.

Part of The McClay Foundation, Almac Clinical Technologies Ltd. is a British company that supplies pharmaceutical products. The private company is based in Craigavon, UK and was founded in 2006.

Part of The McClay Foundation, Almac Sciences Ltd. is a private company based in Craigavon, UK that was founded in 2001. The British company provides custom chemical synthesis, technical testing, and analysis services.

Part of The McClay Foundation, Almac Discovery Ltd. is a British company that engages in the discovery and development of novel drugs. The private company is based in Belfast, UK and was founded in 2003.